221 related articles for article (PubMed ID: 36166152)
1. OCT-Based Biomarkers are Associated with Systemic Inflammation in Patients with Treatment-Naïve Diabetic Macular Edema.
Zhou J; Song S; Zhang Y; Jin K; Ye J
Ophthalmol Ther; 2022 Dec; 11(6):2153-2167. PubMed ID: 36166152
[TBL] [Abstract][Full Text] [Related]
2. Optical Coherence Tomography-Based Grading of Diabetic Macular Edema Is Associated with Systemic Inflammatory Indices and Imaging Biomarkers.
Yanxia C; Xiongyi Y; Min F; Xiaoyun K
Ophthalmic Res; 2024; 67(1):96-106. PubMed ID: 38211574
[TBL] [Abstract][Full Text] [Related]
3. Hyperreflective foci as biomarkers for inflammation in diabetic macular edema: Retrospective analysis of treatment naïve eyes from south India.
Arthi M; Sindal MD; Rashmita R
Indian J Ophthalmol; 2021 May; 69(5):1197-1202. PubMed ID: 33913858
[TBL] [Abstract][Full Text] [Related]
4. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema After Dexamethasone Implants.
Huang YT; Chang YC; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Bair H; Lin JM; Chen WL; Tsai YY
Front Med (Lausanne); 2022; 9():852022. PubMed ID: 35755055
[TBL] [Abstract][Full Text] [Related]
5. Validation of an Automated Artificial Intelligence Algorithm for the Quantification of Major OCT Parameters in Diabetic Macular Edema.
Midena E; Toto L; Frizziero L; Covello G; Torresin T; Midena G; Danieli L; Pilotto E; Figus M; Mariotti C; Lupidi M
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983137
[TBL] [Abstract][Full Text] [Related]
6. Multifocal electroretinogram in diabetic macular edema and its correlation with different optical coherence tomography features.
Khojasteh H; Riazi-Esfahani H; Khalili Pour E; Faghihi H; Ghassemi F; Bazvand F; Mahmoudzadeh R; Salabati M; Mirghorbani M; Riazi Esfahani M
Int Ophthalmol; 2020 Mar; 40(3):571-581. PubMed ID: 31712927
[TBL] [Abstract][Full Text] [Related]
7. Temporal variation of optical coherence tomography biomarkers as predictors of anti-VEGF treatment outcomes in diabetic macular edema.
Maggio E; Mete M; Sartore M; Bauci F; Guerriero M; Polito A; Pertile G
Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):807-815. PubMed ID: 34661731
[TBL] [Abstract][Full Text] [Related]
8. Optical Coherence Tomography Biomarkers in Bilateral Diabetic Macular Edema Patients with Asymmetric anti-VEGF Response.
Koc F; Güven YZ; Egrilmez D; Aydın E
Semin Ophthalmol; 2021 Aug; 36(5-6):444-451. PubMed ID: 33780313
[No Abstract] [Full Text] [Related]
9. Correlating the patterns of diabetic macular edema, optical coherence tomography biomarkers and grade of diabetic retinopathy with stage of renal disease.
Agarwal M; Sachdeva M; Shah S; Raman R; Rani PK; Rajalakshmi R; Sivaprasad S; Vignesh TP; Ramasamy K; Madharia A; Sen A; Sugumar S; Behera UC; Rodrigues AM; Anantharaman G; Priya S; Majumdar A;
Int Ophthalmol; 2022 Nov; 42(11):3333-3343. PubMed ID: 35633427
[TBL] [Abstract][Full Text] [Related]
10. Disorganization of Inner Retina and Outer Retinal Morphology in Diabetic Macular Edema.
Das R; Spence G; Hogg RE; Stevenson M; Chakravarthy U
JAMA Ophthalmol; 2018 Feb; 136(2):202-208. PubMed ID: 29327033
[TBL] [Abstract][Full Text] [Related]
11. Optical Coherence Tomography Parameters Related to Vision Impairment in Patients with Diabetic Macular Edema: A Quantitative Correlation Analysis.
Li B; Zhang B; Chen Y; Li D
J Ophthalmol; 2020; 2020():5639284. PubMed ID: 33062313
[TBL] [Abstract][Full Text] [Related]
12. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema.
Sun JK; Lin MM; Lammer J; Prager S; Sarangi R; Silva PS; Aiello LP
JAMA Ophthalmol; 2014 Nov; 132(11):1309-16. PubMed ID: 25058813
[TBL] [Abstract][Full Text] [Related]
13. Interleaved Optical Coherence Tomography: Clinical and Laboratory Biomarkers in Patients with Diabetic Macular Edema.
Suciu CI; Suciu VI; Cuţaş A; Nicoară SD
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629188
[TBL] [Abstract][Full Text] [Related]
14. Intracystic hyperreflective material in centre-involving diabetic macular oedema.
Venkatesh R; Sangai S; Reddy NG; Sridharan A; Pereira A; Aseem A; Gadde SGK; Yadav NK; Chhablani J
Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2533-2544. PubMed ID: 33710472
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional analysis of morphologic changes and visual outcomes in diabetic macular edema.
Lee H; Kang KE; Chung H; Kim HC
Jpn J Ophthalmol; 2019 May; 63(3):234-242. PubMed ID: 30783942
[TBL] [Abstract][Full Text] [Related]
16. Characterization of peripheral blood inflammatory indicators and OCT imaging biological markers in diabetic retinopathy with or without nephropathy.
Xiaodong L; Xuejun X; Xiaojuan S; Yu H; Mingchao X
Front Endocrinol (Lausanne); 2023; 14():1160615. PubMed ID: 37465123
[TBL] [Abstract][Full Text] [Related]
17. Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.
Yiu G; Welch RJ; Wang Y; Wang Z; Wang PW; Haskova Z
Ophthalmol Retina; 2020 Jan; 4(1):67-76. PubMed ID: 31669329
[TBL] [Abstract][Full Text] [Related]
18. Optical Coherence Tomography and Multifocal Electroretinography in Diabetic Macular Edema: A Neurovascular Relation With Vision.
Nagesh BN; Takkar B; Azad S; Azad R
Ophthalmic Surg Lasers Imaging Retina; 2016 Jul; 47(7):626-31. PubMed ID: 27434893
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of systemic immune-inflammation index in diabetic macular oedema.
Elbeyli A; Kurtul BE; Ozcan SC; Ozarslan Ozcan D
Clin Exp Optom; 2022 Nov; 105(8):831-835. PubMed ID: 34763621
[TBL] [Abstract][Full Text] [Related]
20. Real-life outcomes of intravitreal ranibizumab, aflibercept, and dexamethasone implant administrations in patients with treatment-naïve diabetic macular edema.
Korkmaz A; Karti O; Zengin MO; Yuksel B; Kusbeci T
Saudi J Ophthalmol; 2022; 36(3):327-334. PubMed ID: 36276250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
